Frost & Sullivan to Moderate International Conference at MEDICA 2007

Frost & SullivanHosted by the U.S. Government in partnership with Frost & Sullivan and several strategic partners, the International Conference at MEDICA 2007 is expected to see attendance by every international medical device, equipment and diagnostic company. This pioneering event offers the international medical technology community a unique opportunity to tap the expertise and resources needed to be successful on the world's most important medical market - the USA.

Dorman Followwill, Vice President, Health Care, Frost & Sullivan, who will moderate the conference, notes that this event comes at a time when international medical technology firms, facing strong cost containment pressures, slower growth and challenging regulatory environments, are looking to the U.S. as a rewarding market for innovative products.

"Clearly, the U.S. market offers medical device companies several global competitive advantages," says Followwill. "However, it is essential for international firms to implement the correct strategy on local engagement in the highly competitive U.S. market where volatile currency fluctuations, heightened scrutiny on import safety issues, complex reimbursement systems and regional/local market preferences and practices, all demand careful consideration."

Through this conference, participants will be privy to crucial information and insights aimed at helping international medtech companies establish a presence or expand in the United States. Experts from the U.S. Department of Commerce, its U.S. federal state partners, the U.S. Food and Drug Administration, along with leading industry association officials, company heads and prominent legal, financial and business advisors in the health technology sector will make presentations, participate in panel discussions.

Besides in-depth and insightful information, the forum offers attractive networking opportunities. Attendees can profit from personal consultations with expert speakers and U.S. state representatives during breaks, the relaxed networking reception and in follow on meetings.

In short, anyone responsible for a medical company's global success will find invaluable guidance and networking opportunities on November 13th at the Hilton Hotel, Düsseldorf.

About Frost & Sullivan
Frost & Sullivan, the Growth Consulting Company, partners with clients to accelerate their growth. The company's Growth Partnership Services, Growth Consulting and Career Best Practices empower clients to create a growth focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents. For more information about Frost & Sullivan's Growth Partnerships, visit http://www.frost.com.

Most Popular Now

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Routine AI Assistance may Lead to Loss o…

The introduction of artificial intelligence (AI) to assist colonoscopies is linked to a reduction in the ability of endoscopists (health professionals who perform colonoscopies) to detect precancerous growths (adenomas) in...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...